These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28263741)

  • 1. The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study.
    Bosco P; Redolfi A; Bocchetta M; Ferrari C; Mega A; Galluzzi S; Austin M; Chincarini A; Collins DL; Duchesne S; Maréchal B; Roche A; Sensi F; Wolz R; Alegret M; Assal F; Balasa M; Bastin C; Bougea A; Emek-Savaş DD; Engelborghs S; Grimmer T; Grosu G; Kramberger MG; Lawlor B; Mandic Stojmenovic G; Marinescu M; Mecocci P; Molinuevo JL; Morais R; Niemantsverdriet E; Nobili F; Ntovas K; O'Dwyer S; Paraskevas GP; Pelini L; Picco A; Salmon E; Santana I; Sotolongo-Grau O; Spiru L; Stefanova E; Popovic KS; Tsolaki M; Yener GG; Zekry D; Frisoni GB
    Alzheimers Dement; 2017 Sep; 13(9):1013-1023. PubMed ID: 28263741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series.
    Prestia A; Caroli A; Herholz K; Reiman E; Chen K; Jagust WJ; Frisoni GB; ;
    Alzheimers Dement; 2013 Nov; 9(6):677-86. PubMed ID: 23375562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of Alzheimer's disease in a population attending a memory clinic.
    Frisoni GB; Prestia A; Zanetti O; Galluzzi S; Romano M; Cotelli M; Gennarelli M; Binetti G; Bocchio L; Paghera B; Amicucci G; Bonetti M; Benussi L; Ghidoni R; Geroldi C
    Alzheimers Dement; 2009 Jul; 5(4):307-17. PubMed ID: 19560101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic.
    Morinaga A; Ono K; Ikeda T; Ikeda Y; Shima K; Noguchi-Shinohara M; Samuraki M; Yanase D; Yoshita M; Iwasa K; Mastunari I; Yamada M
    Dement Geriatr Cogn Disord; 2010; 30(4):285-92. PubMed ID: 20861634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey.
    Bocchetta M; Galluzzi S; Kehoe PG; Aguera E; Bernabei R; Bullock R; Ceccaldi M; Dartigues JF; de Mendonça A; Didic M; Eriksdotter M; Félician O; Frölich L; Gertz HJ; Hallikainen M; Hasselbalch SG; Hausner L; Heuser I; Jessen F; Jones RW; Kurz A; Lawlor B; Lleo A; Martinez-Lage P; Mecocci P; Mehrabian S; Monsch A; Nobili F; Nordberg A; Rikkert MO; Orgogozo JM; Pasquier F; Peters O; Salmon E; Sánchez-Castellano C; Santana I; Sarazin M; Traykov L; Tsolaki M; Visser PJ; Wallin ÅK; Wilcock G; Wilkinson D; Wolf H; Yener G; Zekry D; Frisoni GB
    Alzheimers Dement; 2015 Feb; 11(2):195-206.e1. PubMed ID: 25150733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.
    Chiaravalloti A; Barbagallo G; Ricci M; Martorana A; Ursini F; Sannino P; Karalis G; Schillaci O
    Brain Res; 2018 Jan; 1678():116-122. PubMed ID: 29066367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics.
    Prestia A; Caroli A; Wade SK; van der Flier WM; Ossenkoppele R; Van Berckel B; Barkhof F; Teunissen CE; Wall A; Carter SF; Schöll M; Choo IH; Nordberg A; Scheltens P; Frisoni GB
    Alzheimers Dement; 2015 Oct; 11(10):1191-201. PubMed ID: 25646957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment.
    Clerx L; van Rossum IA; Burns L; Knol DL; Scheltens P; Verhey F; Aalten P; Lapuerta P; van de Pol L; van Schijndel R; de Jong R; Barkhof F; Wolz R; Rueckert D; Bocchetta M; Tsolaki M; Nobili F; Wahlund LO; Minthon L; Frölich L; Hampel H; Soininen H; Visser PJ
    Neurobiol Aging; 2013 Aug; 34(8):2003-13. PubMed ID: 23540941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
    Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
    Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting.
    Weise D; Tiepolt S; Awissus C; Hoffmann KT; Lobsien D; Kaiser T; Barthel H; Sabri O; Gertz HJ
    J Alzheimers Dis; 2015; 48(2):425-32. PubMed ID: 26402006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signature.
    Alexopoulos P; Guo LH; Jiang M; Bujo H; Grimmer T; Förster S; Drzezga A; Kurz A; Perneczky R
    J Alzheimers Dis; 2013; 36(2):401-8. PubMed ID: 23609762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI.
    Caroli A; Prestia A; Wade S; Chen K; Ayutyanont N; Landau SM; Madison CM; Haense C; Herholz K; Reiman EM; Jagust WJ; Frisoni GB;
    Alzheimer Dis Assoc Disord; 2015; 29(2):101-9. PubMed ID: 25437302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of neuropsychological tests, neuroimaging, and biomarkers for diagnosing Alzheimer's disease in younger and older age cohorts.
    Schmand B; Eikelenboom P; van Gool WA;
    J Am Geriatr Soc; 2011 Sep; 59(9):1705-10. PubMed ID: 21883100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment.
    Lorenzi M; Donohue M; Paternicò D; Scarpazza C; Ostrowitzki S; Blin O; Irving E; Frisoni GB;
    Neurobiol Aging; 2010 Aug; 31(8):1443-51, 1451.e1. PubMed ID: 20541287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population.
    Bouwman FH; Verwey NA; Klein M; Kok A; Blankenstein MA; Sluimer JD; Barkhof F; van der Flier WM; Scheltens P
    Dement Geriatr Cogn Disord; 2010; 30(1):1-7. PubMed ID: 20606438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fully automated atlas-based hippocampal volumetry for detection of Alzheimer's disease in a memory clinic setting.
    Suppa P; Anker U; Spies L; Bopp I; Rüegger-Frey B; Klaghofer R; Gocke C; Hampel H; Beck S; Buchert R
    J Alzheimers Dis; 2015; 44(1):183-93. PubMed ID: 25201782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Florbetapir positron emission tomography and cerebrospinal fluid biomarkers.
    Hake A; Trzepacz PT; Wang S; Yu P; Case M; Hochstetler H; Witte MM; Degenhardt EK; Dean RA;
    Alzheimers Dement; 2015 Aug; 11(8):986-93. PubMed ID: 25916563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.